Literature DB >> 9675134

Klotho protein protects against endothelial dysfunction.

Y Saito1, T Yamagishi, T Nakamura, Y Ohyama, H Aizawa, T Suga, Y Matsumura, H Masuda, M Kurabayashi, M Kuro-o, Y Nabeshima, R Nagai.   

Abstract

Arteriosclerosis caused by aging is recognized to be a crucial risk factor of cardiovascular disease. We recently established klotho mouse which causes age-related disorders including arteriosclerosis. However, no information on endothelial function of klotho mouse or the physiological role of klotho protein as a circulating factor is available. In this report, we demonstrate that 50% effective dose of aortic relaxation in response to acetylcholine in heterozygous klotho mice is significantly greater (4 x 10(-5) M) than in wild-type mice (8 x 10(-6) M, n = 7, p < 0.05) and that the vasodilator response of arterioles to acetylcholine is significantly attenuated in heterozygous (20% effective dose; 2 x 10(-6) M) and homozygous klotho mice (>1 x 10(-5) M) as compared with wild-type mice (1 x 10(-7) M, n = 7, p < 0.05). Nitric oxide metabolites (NO-2 and NO-3) in urine are significantly lower in heterozygous klotho mice (142 +/- 16 nmol/day) than wild-type mice (241 +/- 28 nmol/day, n = 13, p < 0.05). Parabiosis between wild-type and heterozygous klotho mice results in restoration of endothelial function in heterozygous klotho mice. We conclude that the klotho protein protects the cardiovascular system through endothelium-derived NO production by humoral pathways. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9675134     DOI: 10.1006/bbrc.1998.8943

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  101 in total

Review 1.  The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis.

Authors:  Mark R Haussler; G Kerr Whitfield; Ichiro Kaneko; Ryan Forster; Rimpi Saini; Jui-Cheng Hsieh; Carol A Haussler; Peter W Jurutka
Journal:  Rev Endocr Metab Disord       Date:  2012-03       Impact factor: 6.514

2.  Identification of novel small molecules that elevate Klotho expression.

Authors:  Gwendalyn D King; CiDi Chen; Mickey M Huang; Ella Zeldich; Patricia L Brazee; Eli R Schuman; Maxime Robin; Gregory D Cuny; Marcie A Glicksman; Carmela R Abraham
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

3.  Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.

Authors:  Giovanni Tripepi; Barbara Kollerits; Daniela Leonardis; Mahamut Ilker Yilmaz; Maurizio Postorino; Danilo Fliser; Francesca Mallamaci; Florian Kronenberg; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

4.  Relationship of low-circulating "anti-aging" klotho hormone with disability in activities of daily living among older community-dwelling adults.

Authors:  Candace L Crasto; Richard D Semba; Kai Sun; Anne R Cappola; Stefania Bandinelli; Luigi Ferrucci
Journal:  Rejuvenation Res       Date:  2012-04-24       Impact factor: 4.663

Review 5.  Polymorphism of klotho G-395A and susceptibility of coronary artery disease in East-Asia population: a meta-analysis.

Authors:  Changlin Zhai; Guanmin Tang; Gang Qian; Huilin Hu; Aiming Gu; Ying Fang; Xiaohong Hu; Zhiyong Wang; Shijun Wang; Ming Yao; Jiayin Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 6.  Klotho and aging.

Authors:  Makoto Kuro-o
Journal:  Biochim Biophys Acta       Date:  2009-02-20

7.  P2X7 receptor and klotho expressions in diabetic nephropathy progression.

Authors:  A M Rodrigues; R S Serralha; C Farias; G R Punaro; M J S Fernandes; Elisa Mieko Suemitsu Higa
Journal:  Purinergic Signal       Date:  2018-03-14       Impact factor: 3.765

8.  Klotho protein activates the PKC pathway in the kidney and testis and suppresses 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression.

Authors:  Michio Imai; Kazuhiko Ishikawa; Naomichi Matsukawa; Iwao Kida; Junsuke Ohta; Masashi Ikushima; Yukana Chihara; Xu Rui; Hiromi Rakugi; Toshio Ogihara
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

Review 9.  Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease.

Authors:  Anthony J Donato; Daniel R Machin; Lisa A Lesniewski
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

Review 10.  Fibroblast growth factor 23, Klotho, and disordered mineral metabolism in chronic kidney disease: unraveling the intricate tapestry of events and implications for therapy.

Authors:  Orlando M Gutiérrez
Journal:  J Ren Nutr       Date:  2013-05       Impact factor: 3.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.